Evidence map›Paper›PMID 30337675›Full record

ArticleScientific reports2018

An autoimmune disease risk SNP, rs2281808, in SIRPG is associated with reduced expression of SIRPγ and heightened effector state in human CD8 T-cells.

Sushmita Sinha, Nicholas Borcherding, Pranav S Renavikar, Michael P Crawford, Eva Tsalikian, Michael Tansey, Ezzatollah T Shivapour, Frank Bittner, John Kamholz, Heena Olalde and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Type 1 diabetesNPJ autoimmunity · 2026
    Article
  5. Single-cell transcriptomics reveal circulating skin-homing CLAClinical and translational medicine · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. CD47 and thrombospondin-1 regulation of mitochondria, metabolism, and diabetes.American journal of physiology. Cell physiology · 2021
    Review
  15. De-coding genetic risk variants in type 1 diabetes.Immunology and cell biology · 2021
    Review
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Sushmita SinhaDepartment of Pathology, University of Iowa, 200 Hawkins Dr., Iowa City, IA, 52242, USA. Sushmita-sinha@uiowa.edu.
Nicholas BorcherdingDepartment of Pathology, University of Iowa, 200 Hawkins Dr., Iowa City, IA, 52242, USA.
Pranav S RenavikarDepartment of Pathology, University of Iowa, 200 Hawkins Dr., Iowa City, IA, 52242, USA.
Michael P CrawfordDepartment of Pathology, University of Iowa, 200 Hawkins Dr., Iowa City, IA, 52242, USA.
Eva TsalikianDepartment of Pediatrics, University of Iowa, 200 Hawkins Dr., Iowa City, IA, 52242, USA.
Michael TanseyDepartment of Pediatrics, University of Iowa, 200 Hawkins Dr., Iowa City, IA, 52242, USA.
Ezzatollah T ShivapourDepartment of Neurology, University of Iowa, 200 Hawkins Dr., Iowa City, IA, 52242, USA.
Frank BittnerDepartment of Neurology, University of Iowa, 200 Hawkins Dr., Iowa City, IA, 52242, USA.
John KamholzDepartment of Neurology, University of Iowa, 200 Hawkins Dr., Iowa City, IA, 52242, USA.
Heena OlaldeDepartment of Neurology, University of Iowa, 200 Hawkins Dr., Iowa City, IA, 52242, USA.
Emilee GibsonDepartment of Neurology, University of Iowa, 200 Hawkins Dr., Iowa City, IA, 52242, USA.
Nitin J KarandikarDepartment of Pathology, University of Iowa, 200 Hawkins Dr., Iowa City, IA, 52242, USA.
University of Iowa · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007337 · NIGMS · UNIVERSITY OF IOWA · PI GEYER, PAMELA K., LENTZ, STEVEN R · 1985 to 2020
$15.9M
Immune Dysregulation During Multiple Sclerosis RelapseR01AI121567 · NIAID · UNIVERSITY OF IOWA · PI KARANDIKAR, NITIN J · 2016 to 2020
$3.8M
NIAID NIH HHS R01 AI121567NIGMS NIH HHS T32 GM007337U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI121567
6 · The paper itself

Abstract

Multiple GWAS studies have shown that the SNP rs2281808 TT variant, present within the SIRPG gene, is associated with autoimmune diseases, such as type 1 diabetes. However, the role of SIRPγ in human T-cells is not known, neither is the functional significance of TT variant. Here we investigated SIRPG genotypes and their effects on the fate and function of human T-cells. We found that the presence of T variant resulted in reduction of SIRPγ expression on T-cells. Functionally, SIRPγ

Indexed as

Polymorphism, Single NucleotideAdultAgedAntigens, DifferentiationAutoimmunityCD8-Positive T-LymphocytesCytotoxicity, ImmunologicFemaleGene Expression RegulationGenotypeHumansImmunologic MemoryLymphocyte ActivationMaleMiddle AgedReceptors, ImmunologicAntigens, DifferentiationReceptors, ImmunologicSIRPG protein, human

Identifiers

PMID30337675
PMCPMC6194019
OpenAlexW2896636284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.